Media Room
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results will be reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation will be followed by a Q&A session.
Press releases
December 23, 2025
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
December 19, 2025
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Half year 2025 financial report XBRL package
Half Year 2025 Financial Report
Sustainability Statement 2024 (ESG Report)
Registration Document 2024 (in French)